BBLG Q4 2022 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q4 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$1M

Net Income

$893,460

EPS (Diluted)

$11420154.00

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$62,507

Balance Sheet

Total Assets

$8M

Total Liabilities

$3M

Stockholders' Equity

$6M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$1M	-$458,882	-180.8%
Net Income	$893,460	-$177,737	+602.7%